Inventor
BAMDAD CYNTHIA C
US20 patents
⚠️ This page may combine multiple inventors who share the name “BAMDAD CYNTHIA C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAMDAD CYNTHIA C
7 patentsUS8501921B2Aug 6, 2013
Detection of target analytes using particles and electrodes
BAMDAD CYNTHIA C22 citations92
US8859495B2Oct 14, 2014
Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
BAMDAD CYNTHIA C13 citations83
US8535944B2Sep 17, 2013
Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a Muc1 or Muc1* ligand
BAMDAD CYNTHIA C17 citations83
US10421819B2Sep 24, 2019
MUC1* antibodies
BAMDAD CYNTHIA C7 citations79
US11202775B2Dec 21, 2021
Methods for treatment of cancer
BAMDAD CYNTHIA C2 citations72
US11898160B2Feb 13, 2024
Method for maintaining pluripotency in cells
BAMDAD CYNTHIA C4 citations66
US10042088B2Aug 7, 2018
Optical devices and methods involving nanoparticles
BAMDAD CYNTHIA C0 citations51
HARVARD COLLEGE
5 patentsUS5620850AApr 15, 1997
Molecular recognition at surfaces derivatized with self-assembled monolayers
HARVARD COLLEGE612 citations99
US6809196B2Oct 26, 2004
Molecular recognition at surfaces derivatized with self-assembled monolayers
HARVARD COLLEGE71 citations98
US6306584B1Oct 23, 2001
Electronic-property probing of biological molecules at surfaces
HARVARD COLLEGE90 citations98
US6322979B1Nov 27, 2001
Molecular recognition at surfaces derivatized with self-assembled monolayers
HARVARD COLLEGE54 citations96
US6472148B1Oct 29, 2002
Molecular recognition at surfaces derivatized with self-assembled monolayers
HARVARD COLLEGE41 citations92
MINERVA BIOTECHNOLOGIES CORP
4 patentsUS8344113B2Jan 1, 2013
Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
MINERVA BIOTECHNOLOGIES CORP8 citations84
US7615340B2Nov 10, 2009
Electronic detection of interaction and detection of interaction based on the interruption of flow
MINERVA BIOTECHNOLOGIES CORP11 citations84
US7700715B2Apr 20, 2010
Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
MINERVA BIOTECHNOLOGIES CORP5 citations65
US8349853B2Jan 8, 2013
Compositions and methods of treatment of cancer
MINERVA BIOTECHNOLOGIES CORP2 citations62